InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the full record of transactions filed by Jackson Scott Thomas, Director. Officer active across 3 companies, notably Glycomimetics INC. Cumulatively, 8 disclosures have been published. History available since 18 May 2021. The latest transaction was disclosed on 12 June 2025 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Jackson Scott Thomas
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations8 total
10,000 sharesCommon StockSEC:0001193125-26-283202:0
20,000 shares0Common StockSEC:0000950170-25-087017:0
6,500 sharesCommon StockSEC:0001125345-25-000083:0
20,000 shares0Common StockSEC:0000950170-24-066652:0
4,500 shares0Common StockSEC:0001125345-24-000107:0
20,000 shares0Common StockSEC:0000950170-23-052693:0
15,000 shares0Common StockSEC:0000899243-22-031505:0
5,250 shares0Common StockSEC:0001209191-21-036382:0
8 of 8 declarations
About Jackson Scott Thomas
Scott Thomas Jackson is a Board Member at GlycoMimetics Inc. He contributes to the company's strategy and oversight of its activities. His experience in the biopharmaceutical sector is an asset to the board.
